Diamedica Therapeutics Inc (DMAC)
Operating Income Growth
-23.55%
TTM · Period ending:
DMAC Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-23.55%period ending
Latest reported-23.55%period ending
DMAC TTM Operating Income YoY % (369.04% → -23.55%)
Year-over-year change
High-resolution chart · PNG
DMAC operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -23.5494% | |
| -26.3066% | |
| -28.9195% | |
| -39.3737% | |
| -40.5155% | |
| -35.3563% | |
| -25.4573% | |
| -24.3296% | |
| -28.9178% | |
| -34.4114% | |
| -51.8963% | |
| -46.0901% | |
| -28.0268% | |
| -17.8648% | |
| -2.6015% | |
| 9.5037% | |
| 6.9247% | |
| 2.5226% | |
| -7.4573% | |
| -30.9526% | |
| -38.2054% | |
| -31.562% | |
| -9.5402% | |
| -6.575% | |
| -13.7537% | |
| -24.7478% | |
| -108.9959% | |
| -109.2233% | |
| -221.4% | |
| -5,214.4755% | |
| -384.6939% | |
| -235.0409% | |
| -172.7737% | |
| -95.1473% | |
| -21.9071% | |
| 59.2884% | |
| 155.5489% | |
| 158.24% | |
| 83.9389% | |
| 39.568% | |
| 152.7434% | |
| -14.0161% | |
| -56.8819% | |
| -53.0889% | |
| -89.3481% | |
| -77.0385% | |
| -57.4966% | |
| -61.324% | |
| -45.1613% | |
| -38.2676% | |
| -25.8337% | |
| 85.1951% | |
| 152.9593% | |
| 245.7842% | |
| 240.6873% | |
| 54.861% | |
| 768.6962% | |
| 287.3273% | |
| 202.4243% | |
| 293.5549% | |
| 136.7044% | |
| -44.1922% | |
| -198.7906% | |
| -2,925.7438% | |
| -204.9261% | |
| -149.3017% | |
| -144.7226% | |
| -102.3134% | |
| -40.7179% | |
| -4.885% | |
| 14.3029% | |
| 64.3594% | |
| 69.0889% | |
| 987.0534% | |
| 366.5527% | |
| 869.8302% | |
| 1,343.4943% | |
| 249.5035% | |
| 369.0429% |